New Plans Announced for Full Marketing Approval of Avacopan as Treatment for ANCA Vasculitis
News
In light of upcoming Phase 3 data, ChemoCentryx and Vifor Fresenius Medical Care Renal Pharma have decided not to pursue the conditional approval of avacopan in Europe for patients with ANCA-associated ... Read more